BLOG

KOL ID Roundtable Panel

Roundtable Q&A: The Future of KOL/KEE ID and Mapping

The BioPharma world is a fast-evolving one, but Key Opinion Leaders (KOLs) and Key External Experts (KEEs) remain the core component of transforming awareness into action. What is KOL/KEE Identification and what are some scenarios in which it might be done? KOL/KEE Identification and mapping is pinpointing highly respected, distinguished,

READ MORE »
FDA Approval Stamp

BioPharma Trends in the News – October 2025

The BioPharma industry is in rapid flux, shaped by rising tariffs, shifting policies, and new barriers to prescription access. Here’s a quick look at the forces driving change. Source: Reuters Several major pharmaceutical companies are responding to recent U.S. policy shifts by cutting drug prices and announcing plans to sell

READ MORE »
Magnifying glass identifying an expert

How to Identify Top Experts

Discover proven strategies for selecting the right engagement tools for pharmaceutical Virtual Speaker Programs to create memorable peer-to-peer learning experiences that drive results.

READ MORE »
GLP-1 Administration

BioPharma Trends in the News – September 2025

The BioPharma industry is in rapid flux, shaped by rising tariffs, shifting policies, and new barriers to prescription access. Here’s a quick look at the forces driving change. Source: Time.com The time is now to review your campaigns as FDA oversight ramps up after years of minimal enforcement. Trump’s executive

READ MORE »
Health Insurance Form

BioPharma Trends in the News – August 2025

Source: FiercePharma President Donald Trump is pressing ahead with plans to impose steep tariffs on imported pharmaceuticals—starting small but ramping up to 250%—in a bid to push drug manufacturing back to the U.S. The move, paired with a revived “most favored nation” pricing policy, has already spurred major pharma companies

READ MORE »